Rite Aid Corporation (RAD)
| Previous Close | 11.95 |
| Open | 11.85 |
| Bid | 11.70 x 1800 |
| Ask | 11.72 x 900 |
| Day's Range | 11.68 - 12.10 |
| 52 Week Range | 11.50 - 32.48 |
| Volume | |
| Avg. Volume | 2,218,556 |
| Market Cap | 652.524M |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Oct. 14, 1999 |
| 1y Target Est | N/A |
- Zacks
Solid Demand & Other Efforts Aid Rite Aid (RAD) Amid Cost Woes
Although high costs and a drab view remain concerning, Rite Aid (RAD) looks well-positioned on robust demand, enhanced omni-channel capabilities and strength in PBM.
- Reuters
Designer sunglass company founder to plead guilty to insider trading scheme
The founder of a designer eyewear company whose family has held investments and leadership roles in many major retailers like DSW Inc has agreed to plead guilty to engaging in insider trading with two Florida men using information he learned from a cousin. Federal prosecutors in Boston disclosed in court papers on Thursday that David Schottenstein had agreed to plead guilty https://tmsnrt.rs/3eYbhxW to conspiring to commit securities fraud and cooperate in the prosecution of a venture capital firm founder and an entrepreneur. A lawyer for Schottenstein, the founder of designer sunglasses company Privè Revaux, did not respond to requests for comment.
- Yahoo Finance
COVID-19 home tests: Where to find these in-demand products
At-home testing options are limited in availability, delayed in delivery time, or entirely out of stock depending on the brand and retailer as the Omicron variant surges in the U.S.
